Introduction
Hydrallazine-induced systemic lupus erythematosus (SLE) occurs frequently when hydrallazine is used in a dose of >200 mg/day although a few patients have been reported who developed the syndrome while taking smaller doses (Perry, 1973; Ullman et al., 1974; Harland, Facchini and Timbrell, 1980) . Orogenital ulceration has not previously been reported in association with hydrallazine-or other drug-induced lupus syndrome. Case 
Progress
Hydrallazine was withdrawn and his blood pressure was controlled by propranolol alone. Within one week his mucosal ulcers and the skin rash had disappeared leaving the leg abscess and skin ulcer to resolve more slowly. His total intake of hydrallazine was estimated to be 150 g. Eleven months later he remained free from relapse. Comment Behoet's syndrome has been reported in association with SLE but not when drug-induced (Delrieu et al., 1977) . Like other auto-antibody associated side effects of hydrallazine, orogenital ulceration was completely reversible in this patient when the drug was withdrawn.
It has been suggested that hydrallazine-associated lupus occurs almost exclusively in slow ac-tylators (Strandberg et al., 1976 
